Selected research
Market Structure
Global Polymyxin B Sulfate API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Polymyxin B Sulfate API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Polymyxin B Sulfate API include Yancheng Youhua Pharmaceutical And Chemical Technology, Shandong Luxi Pharmaceutical, Jiangxi Nuclear Industry Reyphon Bio-Chemical, North China Pharmaceutical Huasheng, Hangzhou Zhongmei Huadong Pharmaceutical, Ganzhou Ruizhi Pharmaceutical, Xellia Pharmaceuticals Aps, Rochem International and Medisca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Polymyxin B Sulfate API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Polymyxin B Sulfate API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Polymyxin B Sulfate API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polymyxin B Sulfate API market size, projected growth trends, production technologies, key applications, and end-use industries.
Polymyxin B Sulfate API Segment by Company
Yancheng Youhua Pharmaceutical And Chemical Technology
Shandong Luxi Pharmaceutical
Jiangxi Nuclear Industry Reyphon Bio-Chemical
North China Pharmaceutical Huasheng
Hangzhou Zhongmei Huadong Pharmaceutical
Ganzhou Ruizhi Pharmaceutical
Xellia Pharmaceuticals Aps
Rochem International
Medisca
LGM Pharma
ChemWerth
Biotika As
Alp Pharm
Polymyxin B Sulfate API Segment by Type
Purity ≥99%
95%≤purity≤99%
Polymyxin B Sulfate API Segment by Application
Injection
Others
Polymyxin B Sulfate API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymyxin B Sulfate API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymyxin B Sulfate API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymyxin B Sulfate API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Polymyxin B Sulfate API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymyxin B Sulfate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polymyxin B Sulfate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Polymyxin B Sulfate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥99%
- 95%≤purity≤99%
Applications
- Injection
- Others
Companies covered
- Yancheng Youhua Pharmaceutical And Chemical Technology
- Shandong Luxi Pharmaceutical
- Jiangxi Nuclear Industry Reyphon Bio-Chemical
- North China Pharmaceutical Huasheng
- Hangzhou Zhongmei Huadong Pharmaceutical
- Ganzhou Ruizhi Pharmaceutical
- Xellia Pharmaceuticals Aps
- Rochem International
- Medisca
- LGM Pharma
- ChemWerth
- Biotika As
- Alp Pharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Polymyxin B Sulfate API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Polymyxin B Sulfate API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Polymyxin B Sulfate API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Polymyxin B Sulfate API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Polymyxin B Sulfate API Market Dynamics
- 2.1 Polymyxin B Sulfate API Industry Trends
- 2.2 Polymyxin B Sulfate API Industry Drivers
- 2.3 Polymyxin B Sulfate API Industry Opportunities and Challenges
- 2.4 Polymyxin B Sulfate API Industry Restraints
3 Polymyxin B Sulfate API Market by Manufacturers
- 3.1 Global Polymyxin B Sulfate API Revenue by Manufacturers (2021-2026)
- 3.2 Global Polymyxin B Sulfate API Sales by Manufacturers (2021-2026)
- 3.3 Global Polymyxin B Sulfate API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Polymyxin B Sulfate API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Polymyxin B Sulfate API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Polymyxin B Sulfate API Manufacturers, Product Type & Application
- 3.7 Global Polymyxin B Sulfate API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Polymyxin B Sulfate API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Polymyxin B Sulfate API Players Market Share by Revenue in 2025
- 3.8.3 2025 Polymyxin B Sulfate API Tier 1, Tier 2, and Tier 3
4 Polymyxin B Sulfate API Market by Type
- 4.1 Polymyxin B Sulfate API Type Introduction
- 4.1.1 Purity ≥99%
- 4.1.2 95%≤purity≤99%
- 4.2 Global Polymyxin B Sulfate API Sales by Type
- 4.2.1 Global Polymyxin B Sulfate API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Polymyxin B Sulfate API Sales by Type (2021-2032)
- 4.2.3 Global Polymyxin B Sulfate API Sales Market Share by Type (2021-2032)
- 4.3 Global Polymyxin B Sulfate API Revenue by Type
- 4.3.1 Global Polymyxin B Sulfate API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Polymyxin B Sulfate API Revenue by Type (2021-2032)
- 4.3.3 Global Polymyxin B Sulfate API Revenue Market Share by Type (2021-2032)
5 Polymyxin B Sulfate API Market by Application
- 5.1 Polymyxin B Sulfate API Application Introduction
- 5.1.1 Injection
- 5.1.2 Others
- 5.2 Global Polymyxin B Sulfate API Sales by Application
- 5.2.1 Global Polymyxin B Sulfate API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Polymyxin B Sulfate API Sales by Application (2021-2032)
- 5.2.3 Global Polymyxin B Sulfate API Sales Market Share by Application (2021-2032)
- 5.3 Global Polymyxin B Sulfate API Revenue by Application
- 5.3.1 Global Polymyxin B Sulfate API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Polymyxin B Sulfate API Revenue by Application (2021-2032)
- 5.3.3 Global Polymyxin B Sulfate API Revenue Market Share by Application (2021-2032)
6 Global Polymyxin B Sulfate API Sales by Region
- 6.1 Global Polymyxin B Sulfate API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Polymyxin B Sulfate API Sales by Region (2021-2032)
- 6.2.1 Global Polymyxin B Sulfate API Sales by Region (2021-2026)
- 6.2.2 Global Polymyxin B Sulfate API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Polymyxin B Sulfate API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Polymyxin B Sulfate API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Polymyxin B Sulfate API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Polymyxin B Sulfate API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Polymyxin B Sulfate API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Polymyxin B Sulfate API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Polymyxin B Sulfate API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Polymyxin B Sulfate API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Polymyxin B Sulfate API Revenue by Region
- 7.1 Global Polymyxin B Sulfate API Revenue by Region
- 7.1.1 Global Polymyxin B Sulfate API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Polymyxin B Sulfate API Revenue by Region (2021-2026)
- 7.1.3 Global Polymyxin B Sulfate API Revenue by Region (2027-2032)
- 7.1.4 Global Polymyxin B Sulfate API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Polymyxin B Sulfate API Revenue (2021-2032)
- 7.2.2 North America Polymyxin B Sulfate API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Polymyxin B Sulfate API Revenue (2021-2032)
- 7.3.2 Europe Polymyxin B Sulfate API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Polymyxin B Sulfate API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Polymyxin B Sulfate API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Polymyxin B Sulfate API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Polymyxin B Sulfate API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yancheng Youhua Pharmaceutical And Chemical Technology
- 8.1.1 Yancheng Youhua Pharmaceutical And Chemical Technology Company Information
- 8.1.2 Yancheng Youhua Pharmaceutical And Chemical Technology Business Overview
- 8.1.3 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Product Portfolio
- 8.1.5 Yancheng Youhua Pharmaceutical And Chemical Technology Recent Developments
- 8.2 Shandong Luxi Pharmaceutical
- 8.2.1 Shandong Luxi Pharmaceutical Company Information
- 8.2.2 Shandong Luxi Pharmaceutical Business Overview
- 8.2.3 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Product Portfolio
- 8.2.5 Shandong Luxi Pharmaceutical Recent Developments
- 8.3 Jiangxi Nuclear Industry Reyphon Bio-Chemical
- 8.3.1 Jiangxi Nuclear Industry Reyphon Bio-Chemical Company Information
- 8.3.2 Jiangxi Nuclear Industry Reyphon Bio-Chemical Business Overview
- 8.3.3 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Product Portfolio
- 8.3.5 Jiangxi Nuclear Industry Reyphon Bio-Chemical Recent Developments
- 8.4 North China Pharmaceutical Huasheng
- 8.4.1 North China Pharmaceutical Huasheng Company Information
- 8.4.2 North China Pharmaceutical Huasheng Business Overview
- 8.4.3 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Product Portfolio
- 8.4.5 North China Pharmaceutical Huasheng Recent Developments
- 8.5 Hangzhou Zhongmei Huadong Pharmaceutical
- 8.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
- 8.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
- 8.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Product Portfolio
- 8.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
- 8.6 Ganzhou Ruizhi Pharmaceutical
- 8.6.1 Ganzhou Ruizhi Pharmaceutical Company Information
- 8.6.2 Ganzhou Ruizhi Pharmaceutical Business Overview
- 8.6.3 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Product Portfolio
- 8.6.5 Ganzhou Ruizhi Pharmaceutical Recent Developments
- 8.7 Xellia Pharmaceuticals Aps
- 8.7.1 Xellia Pharmaceuticals Aps Company Information
- 8.7.2 Xellia Pharmaceuticals Aps Business Overview
- 8.7.3 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Product Portfolio
- 8.7.5 Xellia Pharmaceuticals Aps Recent Developments
- 8.8 Rochem International
- 8.8.1 Rochem International Company Information
- 8.8.2 Rochem International Business Overview
- 8.8.3 Rochem International Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Rochem International Polymyxin B Sulfate API Product Portfolio
- 8.8.5 Rochem International Recent Developments
- 8.9 Medisca
- 8.9.1 Medisca Company Information
- 8.9.2 Medisca Business Overview
- 8.9.3 Medisca Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Medisca Polymyxin B Sulfate API Product Portfolio
- 8.9.5 Medisca Recent Developments
- 8.10 LGM Pharma
- 8.10.1 LGM Pharma Company Information
- 8.10.2 LGM Pharma Business Overview
- 8.10.3 LGM Pharma Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 LGM Pharma Polymyxin B Sulfate API Product Portfolio
- 8.10.5 LGM Pharma Recent Developments
- 8.11 ChemWerth
- 8.11.1 ChemWerth Company Information
- 8.11.2 ChemWerth Business Overview
- 8.11.3 ChemWerth Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 ChemWerth Polymyxin B Sulfate API Product Portfolio
- 8.11.5 ChemWerth Recent Developments
- 8.12 Biotika As
- 8.12.1 Biotika As Company Information
- 8.12.2 Biotika As Business Overview
- 8.12.3 Biotika As Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Biotika As Polymyxin B Sulfate API Product Portfolio
- 8.12.5 Biotika As Recent Developments
- 8.13 Alp Pharm
- 8.13.1 Alp Pharm Company Information
- 8.13.2 Alp Pharm Business Overview
- 8.13.3 Alp Pharm Polymyxin B Sulfate API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Alp Pharm Polymyxin B Sulfate API Product Portfolio
- 8.13.5 Alp Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Polymyxin B Sulfate API Value Chain Analysis
- 9.1.1 Polymyxin B Sulfate API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Polymyxin B Sulfate API Production Mode & Process
- 9.2 Polymyxin B Sulfate API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Polymyxin B Sulfate API Distributors
- 9.2.3 Polymyxin B Sulfate API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst